The Impact of Incidental Findings Detected During Brain Imaging on Research Participants of the Rotterdam Study: An Interview Study by Bomhof, C.H.C. et al.
Article
The Impact of Incidental Findings Detected
During Brain Imaging on Research Participants
of the Rotterdam Study: An Interview Study
CHARLOTTE H.C. BOMHOF, LISA VAN BODEGOM, MEIKE W. VERNOOIJ,
WIM PINXTEN, INEZ D. DE BEAUFORT, and ELINE M. BUNNIK
Abstract: This interview study investigates the short- and long-term implications of inci-
dental findings detected through brain imaging on research participants’ lives and their
surroundings. For this study, nine participants of the Rotterdam Scan Study with an
incidental findingwere approached and interviewed.When examining research participants’
narratives on the impact of the disclosure of incidental findings, the authors identified five
sets of tensions with regard to motivations for and expectations of research participation,
preferences regarding disclosure, short- and long-term impacts and impacts on self and
others. The paper shows: (1) that the impact of incidental findings may be greater than
participants at first let on; (2) incidental findings can have significant effects on participants’
social environment; and (3) participants may not feel prepared for disclosure even if
incidental findings have been discussed during the informed consent process. The authors
call for investigators to be aware of research participants’ experiences and these short- and
long-term impacts when designing suitable courses of action for the detection and manage-
ment of incidental findings in research settings.
Keywords: incidental findings; imaging studies; interview study; research ethics; social
impact
Introduction
Around the world, more and more research participants are involved in noninva-
sive imaging-based studies that investigate the human body.1,2,3 With the rise of
new imaging technologies, the quality of the scans is rapidly evolving. Conse-
quently, more details are shown on research scans, including details researchers
were not looking for. Incidental findings have therefore become a rising concern
among researchers.4 Incidental findings are defined as “unexpected observations
of possible clinical significance in healthy subjects or in patients recruited to
research.”5 The prevalence of incidental findings in imaging studies varies from
2.7% to 47%, depending, among other things, on the bodily region, the sequences
acquired, the age of the research participants, and the research setting.6,7,8,9 In
approximately 3.2%–6.6% of otherwise healthy research participants, incidental
findings are detected that are clinically relevant and participants need referral to a
medical specialist.10,11
The potential of discovering incidental findings confronts researchers with an
ethical dilemma. On the one hand, the detection of incidental findings and the
possibility of quick follow-up and treatment may lead to health benefit for the
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research participant.12 But on the other hand, incidental findingsmay cause harmby
giving rise to psychological burdens such as anxiety or emotional distress or even
unnecessary treatment.13,14,15 Incidental findings often lead to clinical follow-up
with the associated medical risks, financial costs, and to what is referred to as
“medicalization.”16,17,18 Although the possible psychological burden is thus
described in the literature, little is known about the consequences of the disclosure
of incidental findings to research participants. Previous research hasmainly focused
on the implications of disclosure of incidental findings in the context of
genomics,19,20 whereas within the field of imaging studies, empirical data on the
impact of incidental findings remain sparse. So far, the ethical implications of
incidental findings in imaging studies have mainly been addressed from the
researcher’s perspective.21,22,23 A few research groups have looked into research
participants’ preferences, mapping the preferences and expectations of research
participants regarding the disclosure of incidental findings.24,25,26,27 This research
showed that >90% of the participants would want to be informed about an
incidental finding, regardless of its clinical relevance.28 Also, most research parti-
cipants expected that if they had abnormalities, these would be discovered through
research imaging, despite being informed otherwise during the informed consent
process.29 Many participants saw participation in a study as a free “health check.”30
This is referred to as the diagnostic misconception: the mistaken belief that the
research (also) aims at uncovering clinically relevant abnormalities.31 Receiving a
(free) health check was an important motivation for participants to take part in a
study.32 Although in principle, early detection of abnormalities can lead to more
timely and effective treatment and thus to health benefit, approximately 76% of the
referred incidental findings in brain imaging are followed by a wait-and-see policy
or discharge from follow-up.33 Schmidt et al. were the first to quantitatively assess
the impact of the disclosure of incidental findings on research participants under-
going whole-body magnetic resonance imaging (MRI), and found that 9.9% of the
participants to whom an incidental finding was disclosed, experienced “strong”
distress and 28.6% experienced “moderate to severe” distress.34 So far, it remains
unclear whether incidental findings cause more benefit than harm. Consequently, it
is still a matter of debate whether and under what conditions researchers should
disclose incidental findings to research participants.
In the past few years the ethical implications of incidental findings have been
identified and several groups have put forward recommendations on the handling
of incidental findings in research settings. Most guidance points to an obligation for
researchers to disclose clinically relevant incidental findings to the partici-
pants.35,36,37 Furthermore, consensus exists that for all research projects involving
imaging of human subjects, a protocol should be developed for the detection,
management, and communication of incidental findings; also, this protocol should
be communicated and agreed upon with the participants during the informed
consent process.38,39 Existing guidance does not stipulate, however, what a respon-
sible protocol for the handling of incidental findings looks like. It is not clear, for
instance, whether researchers should seek to avoid incidental findings (and see it as
a risk or a harm of participating in research) or whether they should “hunt” for
incidental findings (and see it as a potential benefit of participating in research).40
Furthermore, there is still little guidance on practical issues, such as the bestway and
moment to communicate incidental findings. To answer these questions, it is
relevant to know the experiences of research participants, and the impact of the
disclosure of incidental findings on their lives.
The Impact of Incidental Findings Detected During Brain Imaging
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Many large population-based imaging studies are being conducted across the
world, such as the Framingham Heart Study in the United States and the Biobank
study in the United Kingdom.41,42 As the use of imaging technologies in research is
becoming more widespread, it is likely that in the future many other (healthy)
research participants will undergo research imaging. These participants will need to
be informed beforehand about the risks and benefits of study participation. How-
ever, the risks and benefits of being informed about incidental findings are unclear,
as the impact of disclosure on research participants’ lives has not yet fully been
assessed. The aim of this study is to provide an in-depth qualitative analysis of the
finer impacts of incidental findings on research participants’ lives by interviewing
individuals who have dealt with incidental findings in the past about their experi-
ences. This interview study was performed within the Rotterdam Study, a pro-
spective longitudinal cohort study in the city of Rotterdamwhich has been designed
to study causes and consequences of age-related diseases at middle and old age.43
The Rotterdam Study has incorporated brain MRI in their study protocol since 2005
and has almost 15years of experience with the management of incidental findings
detected during research imaging of the brain.
Research Setting
Since the start of the Rotterdam Study in 1990 almost 15,000 participants aged 45
years and over have been enrolled.44 The Rotterdam Study takes place in a single
suburban neighborhood of Rotterdam, and all residents who reach the age of 40 are
invited to participate in the study. Every 3–4years, the participants undergo
extensive interviews, physical examinations and tests, including cognitive testing,
an ECG, and laboratory tests. At the end of the study visit, the participants receive
some clinically relevant individual research results (e.g., blood pressure, lab results,
and hearing results) from the study doctor. Since 2005, all participants also undergo
an MRI scan of the brain as part of the Rotterdam Scan Study.45 With a dedicated
on-site scanner, the Rotterdam Scan Study was one of the first longitudinal
population-based cohort studies to image a large number of healthy research
participants. Acknowledging the importance of an appropriate protocol for the
management of incidental findings and a certain responsibility toward the research
participants, the Rotterdam Study researchers implemented an expert-defined
protocol in which all research scans are reviewed by raters: physician researchers
who are trained to distinguish abnormal from normal brain scans. During the
informed consent process, participants are informed about the possibility of inci-
dental findings and asked whether or not they want incidental findings to be
reported, and whether they want their general practitioner to be informed. When
an abnormality is flagged, the scan is reviewed by a neuroradiologist to confirm the
finding. Incidental findings that are deemed clinically relevant are then disclosed
and communicated with the participant. A list of clinically relevant incidental
findings was established by an expert panel before the start of the study and is
evaluated every 2years. The researchers monitor the follow-up and clinical out-
comes of disclosure,46 but they do not routinely assess the psychological and ethical
implications of disclosure on their research participants. The current study is meant
to fill this gap and to feed into the evaluation of the incidental findings protocol.
Charlotte H.C. Bomhof et al.
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Study Design and Study Participants
In the first approximately 10years of the Rotterdam Scan Study, a total of 549 inci-
dental findings on brain imaging were detected.47 The prevalence of incidental
findings was 9.5%, whereas the prevalence of incidental findings that were con-
sidered in need of clinical referral was 3.2%. All clinically relevant incidental
findingswere disclosed to the research participants. For this study, nine participants
to whom a finding had been disclosed, were interviewed. The aim of the study was
to explore and understand the experiences of research participants with incidental
findings. In order to capture the more subtle impacts on research participants’ lives
and relationships, a qualitative research approach was chosen. The researchers of
the Rotterdam Study provided us with a list of participants with a broad range of
types of incidental findings and follow-up procedures. An overview of the study
participants is shown in Table 1. The participants received a letter containing
detailed information about the interview study and were telephoned after 1week
to ask if they had interest in participating in the study, to answer questions, and
make an appointment. Data saturation was reached after nine interviews. All
participants who were approached chose to participate in the study.
Interviews
Based on the literature, important themes were identified and an interview guide
was developed. Themes included perception of health, informed consent, prefer-
ences concerning the communication of the incidental finding, impact of the
disclosure of the incidental finding and moral attitudes. The interviews were open;
participants were encouraged to speak freely and elaborate on their experiences
with the incidental finding. During the interviews mainly open questions were
asked. The interviews were carried out by one researcher (L.B.) in the summer of
2014 and lasted approximately one and half hour. The interviews took place in the
research center or at the participants’ home, depending on the participants’
Table 1. Study Participants.
Respondent Gender Age rangea
(years)
Incidental finding Clinical management
1 Male 60–70 Cerebral aneurysm Watchful waiting
2 Male 50–60 Pituitary tumor Surgery
3 Male 60–70 Olfactory meningioma Radiotherapy
4 Male 50–60 Pituitary cyst Watchful waiting
5 Female 50–60 Optic nerve glioma Watchful waiting
6 Female 60–70 Cerebral aneurysm Surgery
7 Female 60–70 Pituitary cyst Watchful waiting
8 Female 50–60 Small meningioma near
the trigeminal nerve
Radiotherapy
9 Female 70–80 Convexity meningioma Surgery
a Age provided in ranges for privacy reasons.
The Impact of Incidental Findings Detected During Brain Imaging
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preferences. All interviews were audio-recorded and transcribed verbatim. During
transcription, emotional responses and silences were noted.
Analysis
Interviews were analyzed independently by two researchers (C.B. and E.B.) using
directed content analysis.48 Codes were assigned and refined through multiple
readings. If deemed necessary new codeswere added. Discrepancies in codingwere
solved through discussion. For the coding of the data NVivo 12 qualitative data
software was used.
Results
Based on our analysis of the interviews five key themes were identified. We present
our results according to these key themes.
Motivations for Research Participation and Informed Consent
For the majority of the respondents, the most important reason to participate in the
Rotterdam Studywas to evaluate their health. It was notable that some respondents
even referred to participation in terms of “taking responsibility for their health” and
felt that it would be unwise not to participate.
I’m curious about my health status. And preferably I would want to hear that
everything is okay, but even if it weren’t good, then I would also want to know.
[participant with an olfactory meningioma, radiotherapy]
Most respondents mentioned more than one reason to participate in the study.
Other reasons mentioned were: to contribute to research, to be able to help others,
and to be involved in the research project because others, neighbors, or family
members, were also involved.
Well, it’s two-sided. You participate in the study so researchers get a better picture of
the health of the elderly, I would say. And if I look at myself, I think it’s nice to know
if I’m healthy or not. [participant with a pituitary cyst, watchful waiting]
Although all respondents were primarily motivated by an interest in their own
health to participate in the study, most respondents had never anticipated the
possibility of an incidental finding. Respondents wanted to know about their health
and also wanted to know if anything was amiss, although at the same time, they felt
ill-prepared for an actual finding. Although they had not anticipated the possibility
of an incidental finding, respondents shared the opinion that it would be difficult, if
not impossible, for researchers to better prepare research participants in advance for
the possibility of incidental findings. All respondents had previously signed an
informed consent form which explicitly mentioned the possibility of being con-
fronted with incidental findings. However, not all respondents remembered this.
Even if the possibility of an incidental finding would be discussed more extensively
during the informed consent process, respondents did not believe that they could
have been better prepared for this outcome.
Charlotte H.C. Bomhof et al.
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And as long as you don’t feel anything and you’re functioning fine, everyone
thinks that nothing will be found. [participant with a small meningioma near
the trigeminal nerve, radiotherapy]
Expectations of Research Participation
Most respondents perceived the Rotterdam Study to be a health check. Some
respondents believed that if they did not receive any information back from the
researchers, this meant that they were healthy. However, most respondents were
aware that the absence of any disclosure of detected abnormalities did not neces-
sarily guarantee a “clean bill of health.”
Yes, yes, I understand it’s not a total body check. Yes, I’m very aware of that.…
No, I don’t let my entire health depend on the Rotterdam Study. [participant
with a small meningioma near the trigeminal nerve, radiotherapy]
All respondents expected that researchers (or doctors) would check the MRI scans
for abnormalities in the brain and that abnormalities would be detected and
disclosed. Respondents also felt that researchers were morally obligated to search
for incidental findings in exchange for their participation in the study. By contrast,
some respondents felt that researchers should only look at data necessary for their
research questions, and should not feel obligated to look at data beyond the scope of
their research question. There was a tension between respondents’ perceptions of
research as science on the one hand, and their expectations of researchers’ respon-
sibilities for the health of participants and their perception of research as an
individual health check on the other hand.
In my opinion if you [as a researcher] do something like this [an MRI], then
you’re obligated to look at it very closely. Otherwise, why would you do it?
[participant with an optic nerve glioma, watchful waiting]
Preferences with Regard to Disclosure
Almost all respondents wanted all incidental findings to be reported, regardless of
their clinical relevance or the possibility of treatment.
If nothing can be done about it I would still want to know. Because then I would…
well, maybe enjoy things more during the last period… That’s what I would think.
I’m aware it’s also a burden [for partner and daughter]. But I would still want
to know, because then you can take measures. [participant with a cerebral
aneurysm, surgery]
Respondents offered multiple reasons why they wanted incidental findings to be
disclosed. The most important reason was the possibility of health benefit and
treatment. Another important reason was respect for the autonomy of the partici-
pant. Respondents felt strongly that they should be informed about anything that
may be going on in their own body, regardless of the possible clinical relevance.
The Impact of Incidental Findings Detected During Brain Imaging
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They felt that they had an ownership over the data concerning their own body.
Respondents felt that they should decide whether or not knowing about the
incidental finding is relevant or useful. They also referred to a moral principle of
reciprocity; in return for their participation, they have a right to know if something is
going on.
Yes, openness on behalf of my health. Not openness because of the openness. But
I offer my time and body for all sorts of testing, then if something comes forward
which is relevant for me, then I have the right or I deserve to hear it. [participant
with a meningioma, surgery]
I don’t know. I think it’s ethically incorrect, if something is wrong with someone,
because that’s what we’re talking about, to withhold information from that person.
I think that everyone has the right to know what’s going on. [participant with a
pituitary tumor, surgery]
Most respondents were glad that the incidental finding had been reported. For some
participants the disclosure of the incidental finding came as a relief.
For me it was, it sounds crazy, a relief that it had been found. Because when I said
this headache, it isn’t migraine but something else…. It was a confirmation that
I had been right all along. So that has been very positive. I’ve felt it right, I felt it
right all along. [participant with a cerebral aneurysm, surgery]
Suppose that after all it is something abnormal? Now I’m being checked every
time. Yes, the doctor also asked me, isn’t it a burden to come to the hospital every
time? I told him I’d rather have 10 more MRIs, than that I wouldn’t be allowed to
come for the next 5 years. [participant with an optic nerve glioma, watchful
waiting]
Despite their preferences for the feedback of information on incidental findings,
respondents did consider reasons not to report findings. One frequently mentioned
reasonwas the psychological burden that comes with the disclosure of an incidental
finding.Most respondents considered themselves to be down-to-earth and said that
they felt competent at dealing psychologically with the disclosure of the finding, but
they could imagine that other people might experience more emotional distress.
Also, clinical relevancewas taken into consideration; one participant believed that if
an incidental finding did not have any clinical relevance, it should not be disclosed.
Respondents also underlined how stressful the first period was after the incidental
finding was disclosed.
If I don’t look at myself, but at other people, I think it can be very tough to live in
uncertainty and fear all this time… Look, you don’t wish this for anyone; the
nerves, the stress you experience before the examinations… Like I said, I wouldn’t
like to repeat those first 7 months. [participant with an optic nerve glioma,
watchful waiting]
Furthermore, age was mentioned as a factor which should be taken into account
when reporting incidental findings. Two participants mentioned that now that they
were older, they were better able to put things in perspective and that they wanted
Charlotte H.C. Bomhof et al.
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incidental findings to be disclosed, but that this might not have been the case when
they were younger.
When you’re younger, and if then you already have to carry such pressure… like
‘it might turn out the wrong way for me…’ I wouldn’t know what my opinions
would have been then [about the disclosure of an incidental finding].
[participant with an olfactory meningioma, radiotherapy]
Respondents thought that as part of the informed consent process, participants
should be offered a choice whether or not they want incidental findings to be
disclosed. Respondents felt that whether they want incidental findings to be
disclosed is a personalmatter that is different for every individual and that therefore
that choice should always be made by the research participants themselves.
Short-Term and Long-Term Impact
Immediately after the disclosure of the incidental finding, nearly all respondents
experienced shock and disbelief. They all still remember the moment they were
informed very vividly. The disclosure of the incidental finding had a substantial
impact on the lives of the respondents in the first period after the disclosure and
some respondents experienced emotional distress in the first few months.
I was just taken off guard. I was just completely taken off guard, that’s how I
experienced it. [participant with an optic nerve glioma, watchful waiting]
And also after the first phone call. Then you’re at a total loss what to do. And then
you discuss it over here [in the research center]and you accept it. But afterwards
I’ve been worrying the entire night. I’ve dropped out for two days with migraine
headaches. [participant with a small meningioma near the trigeminal nerve,
radiotherapy]
However, two respondents said that they did not experience any shock when they
heard the news.
No not at all. No, why be scared if you don’t even know yet what’s going on. So
no. That’s still possible afterwards [after more examination]. [participant with
a pituitary tumor, surgery]
In the long term, the respondents said that the disclosure of the incidental finding
had little impact on their lives. All respondents said they were able to deal with the
disclosure of the incidental finding adequately, and none of the respondents said
they experienced emotional distress in the long term. However, some respondents
did still experience some momentary stress during follow-up examinations.
The doctor had reassured me and then I’ve stopped thinking about it. Sometimes it
comes up, then I think hey there’s something going on over there [in the brain].
I could worry about it every day, but that wouldn’t help either. [participant with
a pituitary cyst, discharged from follow-up]
If you know it for a few months and nothing happens, then it [the fear] fades.
[participant with a cerebral aneurysm, watchful waiting]
The Impact of Incidental Findings Detected During Brain Imaging
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For all respondents, the disclosure of the incidental finding did not have any effect on
the perception of their health, even as they are still undergoing routine check-ups.
Respondents with an incidental finding which could be treatedwere thankful that the
incidental finding had been found. In some cases, due to early intervention, a great
deal of suffering could be avoided. For that, research participants were very grateful.
Respondents were pleased with the procedure concerning the incidental finding
and especially appreciated the brief waiting time (a few days at most) between
the disclosure of the incidental finding and the hospital appointment for further
diagnostic evaluation. Most respondents were content with the disclosure of the
incidental finding by a principal investigator involved in the Rotterdam Study,
some respondents would have preferred it if the incidental findingwas disclosed by
their general practitioner. All respondents agreed to letting their general practi-
tioner be informed (by letter) about the incidental finding.
Impact on Respondents and Their Social Surroundings
As mentioned above, almost all respondents considered themselves to be down-to-
earth and, when asked, they said that they did not experience emotional distress in
the long term. However, they did offer narratives about the impact of the incidental
finding on their lives that suggested otherwise. Some respondents wondered
whether they might have been better off not knowing. For instance, one respondent
mentioned that every time he had a headache, he wondered whether it had
something to do with the finding.
Well…Every time I have a headache, I think…. it won’t have something to do with
it [the incidental finding], will it? That’s a disadvantage. God, will it be that?
[the incidental finding]. Yes of course that’s the case, that’s part of your world
now. [participant with an olfactory meningioma, radiotherapy]
Also, multiple respondents had follow-up examinations for a few years, which did
have an impact on their lives.
You do realize, but that’s an emotion of course, that well, during multiple years
you will have to get a scan. You’re part of a circuit now, of which you never were
part before. In fact, you have to give up your independence, you are at the mercy of
the healthcare system in the hospital, and that’s a strange sensation. Yes, that’s not
pleasant. [participant with an olfactory meningioma, radiotherapy]
The respondents perceived the impact of disclosure of the incidental findings on
themselves as small. However, they did talk about the more serious impact on their
direct social environment. Multiple respondents mentioned a serious impact on the
people surrounding them.
And yes, at some time you’re able to get some peace. And then you tell it to
everyone at the office and you tell your family… And strangely enough you
becomemuch calmer...While the people surrounding you are scared to death. They
weremuchmore scared then I was. [participantwith a smallmeningioma near
the trigeminal nerve, radiotherapy]
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One respondent mentioned that at her daughter’s wedding, she found out
how much her daughter had been affected by the news and had been worrying
about her.
But also for the people surrounding you. Your children for instance. I know they
have been worrying a lot. You’re their mother, and one [of my children] was
going to get married, and the other one wanted to get married. And they thought
‘What if [mother] isn’t here anymore to see it?’ They told me afterwards, at their
wedding, through the wedding official –my daughter wanted to say something but
she couldn’t do it herself. She had been worrying so much. I found that very
upsetting, because she couldn’t even… [tell me].And that she had the feeling like,
I have to hurry because maybe mom wouldn’t be able to see me in my wedding
dress. [participant with an optic nerve glioma, watchful waiting]
Another respondent with a cerebral aneurysm mentioned that although she was
rather calm herself, her partner had been frightened. In his family someone had died
because of a ruptured aneurysm, and therefore he wanted to inform her daughter
immediately.
He [her partner] said: ‘Will you please sit down?’ Well.. he knew what it
[an aneurysm] was. In his family, a family member had had a ruptured
aneurysm. So he was scared to death. And so he arrived and he said ‘Does [her
daughter] know?’ I have one daughter. I said no. He says: ‘Put your shoes on and
come!’And I thought, I don’t understand what he’s up to. I said ‘Oh she’s coming
on Thursday, I’ll tell her then’. He said ‘No, we’re going to [see her] now! Well
and when we arrived, he told her what was going on and that it was rather
dangerous. [participant with a cerebral aneurysm, surgery]
Discussion
Until now, qualitative studies have mainly focused on the preferences and expect-
ations of research participants regarding the procedural aspects of the disclosure of
incidental findings in imaging studies.49,50,51 These previous findings are largely in
accordance with the results of this study; participants preferred a short waiting time
between the disclosure of the incidental finding and clinical follow-up, they
preferred the communication of the finding to be done by a researcher who was
involved in the study, and they all agreed to letting their general practitioner be
informed. In accordance with those studies, our study also showed that research
participants have expectations regarding imaging studies that researchersmight not
always be aware of. For instance, research participants expect researchers to always
check for abnormalities. Moreover, research participants have a strong preference
for being informed about incidental findings. Researchers and ethics committees
need to be aware of participants’ preferences and expectations regarding the
procedural aspects of the disclosure of incidental findings, so that they can accom-
modate or address these in their procedures. In this study however,we have focused
not on thesemore procedural aspects but on understanding the impact andmeaning
of the disclosure of an incidental finding on the lives of research participants.
In our in-depth interviewswith research participants, we noticed tensions in their
narratives ofwhat had happened to them and how they evaluated their experiences.
The Impact of Incidental Findings Detected During Brain Imaging
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There were tensions between their experiences at the time of hearing about the
incidental finding and their valuations of knowing about the finding in the present.
Learning about the finding was a shock at first, they would typically say, but now
they have adjusted and are copingwell. Also, on the one hand, they say that they are
happy to know about the finding, on the other hand, some suggest that they might
have been better off not knowing.
One of the most striking findings in our study was the discrepancy between
participants’ explicit and implicit valuations of the impact of the incidental finding
on themselves and on their lives. When asked by the interviewer, participants
initially reported that the incidental finding had a relatively small impact on them
psychologically. Further on in the interview, however, participants’ narratives
revealed an evidently larger impact both on the participants themselves and on
their loved ones and social environment. One dramatic example is a respondent’s
story of the role the incidental finding had played on her daughter’s wedding day.
The participant had been informed about a small meningioma that may very well
remain asymptomatic for years—or for good—but that caused her and those
surrounding her to worry deeply nonetheless. Partners, children and other loved
ones of research participants may be affected, too, duly or unduly, by the
implications of the incidental finding. Until now, this impact on the social
environment has not fully been described in the literature. Therefore, this makes
us question whether the actual impact of incidental findings on participants’ lives
might be greater than has been suggested based on previous studies. These
“hidden harms,” these softer impacts on the lives of research participants and
their loved ones, merit further attention from psychologists and medical ethicists
in the future.
Nearly all of our participants mentioned the shock they first experienced when
the incidental finding was reported to them and the emotional distress it gave rise
to in the first few weeks and months. Ultimately, however, all participants were
satisfied with the disclosure of the incidental finding. Even those who may not
have gainedmedical benefit were happy that they knew about the finding. This is
in accordance with previous research regarding the impact of incidental find-
ings.52 This could be explained by a similar mechanism that is known from ethical
discussions on population screening andwhatwewould like to call the concept of
the positive feedback loop. The mechanism underlying this concept has been
referred to before in the context of incidental findings.53 When participating in
screening, individuals will tend to be positive about the outcome: if no abnor-
malities are found, individuals will be happy that they have been checked, as they
now feel reassured, and if abnormalities are found, participants will be happy
that the abnormality was detected early as it can now be treated or monitored and
(possibly) benefit their health. Therefore, one could argue that, after overcoming
the initial shock, participants will always be content with the disclosure of an
incidental finding. This concept of the “positive feedback loop” might explain
why at first glance, the drawbacks of incidental findings tend to remain under-
exposed.
Most participantswanted all incidental findings to be reported, regardless of their
clinical relevance. Participants simplywanted to knowanything that the researchers
may have detected, even if the finding may be difficult to interpret or not actionable
clinically. This is largely in accordance with previous studies,54,55,56 but this is not
in accordance with current ethical guidance, which states that only potentially
Charlotte H.C. Bomhof et al.
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clinically relevant findings should be reported.57 Respondents cited the principle of
autonomy, feeling that they should receive all information concerning their own
bodies. They themselves should decide whether or not a finding is relevant,
clinically or personally. They also referred to the moral principle of reciprocity: in
return for their contribution to the research project, they expect researchers to look
for incidental findings and to act on them. Previous research has shown that not only
participants, but researchers too, recognize the principle of reciprocity.58 Some
participants also cited personal utility: even if a finding may not lead to medical
benefit, it could be useful from a personal perspective, for instance, in making
important life changes. This argument, however, may not apply to findings of
limited clinical validity; when it is not clear what the finding means for the
participant’s (future) health, there may not be any personal utility to be gained
and participants might even experience harm.59 Therefore, a principle of reciprocity
may pertain to findings detected in the course of research that constitute informa-
tion of potential (clinical) relevance to research participants, but itmay not pertain to
findings that are uninterpretable (and do not constitute information at all). How-
ever, this could change in the future. Societal trends such as large-scale data
collection together with a growing belief that people should own their own health
data, might give rise to changes in how we evaluate current ethical guidance.
Another important finding in our studywas that although their health status was
an important motivation for participation in the Rotterdam Study and respondents
wanted to be informed, they were not prepared for an actual finding. Even though
the possibility of an incidental finding had been explicitly discussed during the
informed consent process, participants felt ill-prepared, and sometimes did not even
remember that it was discussed. It is well known that participants often forget or
misinterpret what has been said during informed consent processes.60 Our respond-
ents, however, believed that even if informed consent discussions would be more
extensive, they would still not have been prepared for incidental findings. Further-
more, our study also showed that a majority of the participants regarded the
research as a health check, despite being told otherwise during the informed consent
process, marking the occurrence of diagnostic misconceptions.61 This too, empha-
sizes the importance of future research into expectationsmanagement regarding the
disclosure of individual research results and adequate communication of the
possibility of incidental findings during the informed consent process.
The current study has several limitations. First, in this study, only participants
who in the first place wanted incidental findings to be disclosed were interviewed.
This might have caused a selection bias which could have led to a more optimistic
picture of research participants’ experiences. Second, the Rotterdam Study is a large
cohort with a clear, careful and rigorous protocol concerning incidental findings. In
smaller cohorts with less experience with incidental findings, the experience of
participants might be different. Finally, another limitation of this study is the small
sample size (n=9). However, the aim of this studywas to understand the impact the
disclosure of an incidental finding may have on the lives of individual research
participants, and for this reason, we used extensive, in-depth qualitative interviews
with a few individual research participants, rather than more cursory surveys of
larger groups of participants. The interviews allowed us to extract examples,
memories, after-thoughts, and tensions in their narratives. By using a narrative
approach our study provided fine-grained insight into respondent’s views that
might not have been obtained by asking respondents to fill out questionnaires.
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Conclusion
By closely examining research participants’ narratives on the impact of the disclos-
ure of incidental findings and the tensions that came forward during our interviews,
some important lessons can be learned. First, the impact of incidental findings on the
lives of participants may sometimes be greater than participants let on at first.
Second, incidental findings can also have a significant impact on the social envir-
onment of the research participants. Until now, this impact on the people surround-
ing the research participant has never fully been described in the literature. Third,
participants do not feel prepared for the disclosure of an incidental finding, even if it
has been discussed during the informed consent process and even if they have
consented to being informed of clinically relevant abnormalities. It is important for
researchers, research managers, policymakers, and members of research ethics
review committees to be aware of these existing tensions in research participants’
expectations and experiences, for this may help them to design suitable courses of
action for the detection, management, and communication of incidental findings in
research.
Funding
This study is a result of the research project “Previously healthy? An ethical
approach of incidental findings through imaging studies,” which was funded by
ZonMW, dossier number 731010004 (2013–2015). Additional funding for this
project was awarded to Eline Bunnik by the WiRe Fellowship Program at the
University of Münster, Germany (2019).
Notes
1. Morris Z, Whiteley WN, Longstreth WT, Jr., Weber F, Lee YC, Tsushima Y, et al. Incidental findings
on brain magnetic resonance imaging: Systematic review and meta-analysis. British Medical Journal
2009;339:b3016.
2. Illes J, KirschenMP, Edwards E, Stanford LR, Bandettini P, ChoMK, et al. Ethics: Incidental findings
in brain imaging research. Science 2006;311(5762):783–4.
3. Ikram MA, van der Lugt A, Niessen WJ, Koudstaal PJ, Krestin GP, Hofman A, et al. The Rotterdam
Scan Study: Design update 2016 and main findings. European Journal of Epidemiology 2015;30
(12):1299–315.
4. Bunnik EM, van Bodegom L, Pinxten W, de Beaufort ID, Vernooij MW. Ethical framework for the
detection, management and communication of incidental findings in imaging studies, building on an
interview study of researchers' practices and perspectives. BMC Medical Ethics 2017;18(1):10.
5. Illes J, Kirschen MP, Edwards E, Bandettini P, Cho MK, Ford PJ, et al. Practical approaches to
incidental findings in brain imaging research. Neurology 2008;70(5):384–90.
6. See note 1, Morris et al. 2009.
7. Illes J, RosenAC,Huang L, Goldstein RA, Raffin TA, SwanG, et al. Ethical consideration of incidental
findings on adult brain MRI in research. Neurology 2004;62(6):888–90.
8. Bos D, Poels MM, Adams HH, Akoudad S, Cremers LG, Zonneveld HI, et al. Prevalence, clinical
management, and natural course of incidental findings on brain MR images: The population-based
Rotterdam Scan Study. Radiology 2016;281(2):507–15.
9. Vernooij MW, Ikram MA, Tanghe HL, Vincent AJ, Hofman A, Krestin GP, et al. Incidental findings
on brain MRI in the general population. New England Journal of Medicine 2007;357(18):1821–8.
10. See note 7, Illes et al. 2004.
11. See note 8, Bos et al. 2016.
12. See note 8, Bos et al. 2016.
13. See note 2, Illes et al. 2006.
Charlotte H.C. Bomhof et al.
554
D
ow
nl
oa
de
d 
fr
om
 h
tt
ps
:/
/w
w
w
.c
am
br
id
ge
.o
rg
/c
or
e.
 IP
 a
dd
re
ss
: 8
4.
24
1.
20
1.
76
, o
n 
07
 O
ct
 2
02
0 
at
 1
1:
57
:5
4,
 s
ub
je
ct
 to
 th
e 
C
am
br
id
ge
 C
or
e 
te
rm
s 
of
 u
se
, a
va
ila
bl
e 
at
 h
tt
ps
:/
/w
w
w
.c
am
br
id
ge
.o
rg
/c
or
e/
te
rm
s.
 h
tt
ps
:/
/d
oi
.o
rg
/1
0.
10
17
/S
09
63
18
01
20
00
03
04
14. Booth TC, Jackson A, Wardlaw JM, Taylor SA, Waldman AD. Incidental findings found in "healthy"
volunteers during imaging performed for research: Current legal and ethical implications. British
Journal of Radiology 2010;83(990):456–65.
15. Schmidt CO, Hegenscheid K, Erdmann P, Kohlmann T, Langanke M, Volzke H, et al. Psychosocial
consequences and severity of disclosed incidental findings from whole-body MRI in a general
population study. European Journal of Radiology 2013;23(5):1343–51.
16. See note 15, Schmidt et al. 2013.
17 Wardlaw JM, Davies H, Booth TC, Laurie G, Compston A, Freeman C, et al. Acting on incidental
findings in research imaging. British Medical Journal 2015;351:h5190.
18. Orme NM, Fletcher JG, Siddiki HA, HarmsenWS, O'Byrne MM, Port JD, et al. Incidental findings in
imaging research: Evaluating incidence, benefit, and burden. Archives of Internal Medicine 2010;170
(17):1525–32.
19. Jelsig AM, Qvist N, Brusgaard K, Ousager LB. Research participants in NGS studies want to know
about incidental findings. European Journal of Human Genetics 2015;23(10):1423–6.
20. Brothers KB, East KM, KelleyWV,WrightMF,WestbrookMJ, Rich CA, et al. Eliciting preferences on
secondary findings: The preferences instrument for genomic secondary results. Genetics in Medicine
2017;19(3):337–44.
21. Wolf SM, Lawrenz FP, Nelson CA, Kahn JP, Cho MK, Clayton EW, et al. Managing incidental
findings in human subjects research: Analysis and recommendations. Journal of Law, Medicine and
Ethics 2008;36(2):219–48.
22. See note 4, Bunnik et al. 2017.
23. VazM, VazM, Srinivasan K. The views of ethics committee members andmedical researchers on the
return of individual research results and incidental findings, ownership issues and benefit sharing in
biobanking research in a South Indian city. Developing World Bioethics 2018;18(4):321–30.
24. See note 15, Scmidt et al. 2013.
25. KirschenMP, Jaworska A, Illes J. Subjects' expectations in neuroimaging research. Journal of Magnetic
Resonance Imaging 2006;23(2):205–9.
26. de Boer AW, Drewes YM, de Mutsert R, Numans ME, den Heijer M, Dekkers OM, de Roos A, et. al.
Incidental findings in research: A focus group study about the perspective of the research participant.
International Society for Magnetic Resonance in Medicine 2018;47(1):230–7.
27. Hegedus P, von Stackelberg O, Neumann C, Selder S, Werner N, Erdmann P, et al. How to report
incidental findings from population whole-body MRI: View of participants of the German National
Cohort. European Journal of Radiology 2019;29(11):5873–8.
28. See note 25, Kirschen et al. 2006.
29. See note 26, de Boer et al. 2018.
30. See note 20, Brothers et al. 2017.
31. Nobile H, Vermeulen E, Thys K, Bergmann MM, Borry P. Why do participants enroll in population
biobank studies? A systematic literature review. Expert Review of Molecular Diagnostics 2013;13
(1):35–47.
32. See note 26, de Boer et al. 2018.
33. See note 8, Bos et al. 2016.
34. See note 15, Schmidt et al. 2013.
35. See note 21, Wolf et al. 2008.
36 The Presidential Commission for the Study of Bioethical Issues. Anticipate and communicate:
Management of incidental and secondary findings in the clinical, research, and direct-to-consumer
contexts 2013.
37. Bunnik EM, Vernooij MW. Incidental findings in population imaging revisited. European Journal of
Epidemioogyl 2016;31(1):1–4.
38. See note 4, Bunnik et al. 2017.
39. See note 21, Wolf et al. 2008.
40. Wouters RHP, Bijlsma RM, Frederix GWJ, Ausems M, van Delden JJM, Voest EE, et al. Is it our duty
to hunt for pathogenic mutations? Trends in Molecular Medicine 2018;24(1):3–6.
41. Palmer LJ. UK Biobank: Bank on it. Lancet 2007;369(9578):1980–2.
42. DeCarli C, Massaro J, Harvey D, Hald J, Tullberg M, Au R, et al. Measures of brain morphology and
infarction in the framingham heart study: Establishing what is normal.Neurobiology of Aging 2005;26
(4):491–510.
43. Ikram MA, Brusselle GGO, Murad SD, van Duijn CM, Franco OH, Goedegebure A, et al. The
Rotterdam Study: 2018 update on objectives, design and main results. European Journal of Epidemi-
ology 2017;32(9):807–50.
The Impact of Incidental Findings Detected During Brain Imaging
555
D
ow
nl
oa
de
d 
fr
om
 h
tt
ps
:/
/w
w
w
.c
am
br
id
ge
.o
rg
/c
or
e.
 IP
 a
dd
re
ss
: 8
4.
24
1.
20
1.
76
, o
n 
07
 O
ct
 2
02
0 
at
 1
1:
57
:5
4,
 s
ub
je
ct
 to
 th
e 
C
am
br
id
ge
 C
or
e 
te
rm
s 
of
 u
se
, a
va
ila
bl
e 
at
 h
tt
ps
:/
/w
w
w
.c
am
br
id
ge
.o
rg
/c
or
e/
te
rm
s.
 h
tt
ps
:/
/d
oi
.o
rg
/1
0.
10
17
/S
09
63
18
01
20
00
03
04
44. See note 43, Ikram et al. 2018.
45. See note 3, Ikram et al. 2016.
46. See note 9, Vernooij et al. 2007.
47. See note 8, Bos et al. 2018.
48. Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qualitative Health Research
2005;15(9):1277–88.
49. See note 25, Kirschen et al. 2006.
50. See note 26, de Boer et al. 2018.
51. See note 27, Hegedus et al. 2019.
52. See note 15, Schmidt et al. 2013.
53. See note 26, de Boer et al. 2018.
54. See note 25, Kirschen et al. 2006.
55. See note 26, de Boer et al. 2018.
56. See note 27, Hegedus et al. 2019.
57. See note 36, The Presidential Commission for the Study of Bioethical Issues 2013.
58. See note 4, Bunnik et al. 2017.
59. Bunnik EM, Janssens AC, Schermer MH. Personal utility in genomic testing: Is there such a thing?
Journal of Medical Ethics 2015;41(4):322–6.
60. Grady C. Enduring and emerging challenges of informed consent. New England Journal of Medicine
2015;372(9):855–62.
61. See note 31, Nobile et al. 2013.
Charlotte H.C. Bomhof et al.
556
D
ow
nl
oa
de
d 
fr
om
 h
tt
ps
:/
/w
w
w
.c
am
br
id
ge
.o
rg
/c
or
e.
 IP
 a
dd
re
ss
: 8
4.
24
1.
20
1.
76
, o
n 
07
 O
ct
 2
02
0 
at
 1
1:
57
:5
4,
 s
ub
je
ct
 to
 th
e 
C
am
br
id
ge
 C
or
e 
te
rm
s 
of
 u
se
, a
va
ila
bl
e 
at
 h
tt
ps
:/
/w
w
w
.c
am
br
id
ge
.o
rg
/c
or
e/
te
rm
s.
 h
tt
ps
:/
/d
oi
.o
rg
/1
0.
10
17
/S
09
63
18
01
20
00
03
04
